Alexander H Russell,
Send response to journal:
Christopher J Noble has misunderstood my basic argument: wherever you find localised recreational drug epidemics (Eastern Europe and the Far East) you will observe high rates of ‘HIV’ positivity: these rising drug- epidemics are cynically being reclassified as ‘AIDS’ epidemics. Thus the putative ‘HIV’ test can just as equally indicate localised drug addiction, exposure to malaria, TB and leprosy. Indeed, ironically the only thing the ‘HIV’ test doesn’t test for is ‘HIV’.
Why is there such a striking correlation between drug consumption and ‘HIV’ positivity – even amongst prostitute women?
Those areas that do not have drug epidemics do not have 'AIDS' (apart from India and Africa where TB, malaria, and diseases relating to poverty have been cynically revamped as 'AIDS').
Can Mr. Noble supply me with any information - scientific references, etc of 'AIDS' epidemics in areas that are not prone to drug addiction, malaria, TB, poor hygiene and malnutrition?
If, as Mr. Noble suggests, 'AIDS' is caused by a transmissible agent why has it avoided those areas where there is no drug addiction, no malaria, or TB as well as poverty and malnutrition? Where is the white Western 'AIDS' epidemic?
Mr. Noble appears to be wilfully blind to the clear correlation and connection between recreational drug use and testing ‘HIV’ positive: indeed the so-called ‘HIV’ test seems to be a recreational drug test and not a test for ‘HIV’ (which does not exist). So-called ‘HIV positivity’ is merely an indicator of ‘risk behaviour’ – and in this case, of drug consumption/addiction.
Remember those 32 South African boxers who were alleged to have been 'infected' by Natal prostitutes? Were they taking performance-enhancing drugs?
Can Mr. Noble identify a single paper which clearly demonstrates the recovery of even one single ‘HIV’ particle from a fresh sample of any bodily fluid taken from an alleged ‘HIV’ positive person? I am not interested in cultural/laboratory artefacts; I am talking about fluid taken directly from a patient deemed to be ‘HIV’ positive according to current standards. I challenge him to produce one reference, backed up by electronmicroscopic evidence. Surrogate markers ('virtual virology') will not suffice.
Here are two Peter Duesberg references:
AIDS ACQUIRED BY DRUG CONSUMPTION AND OTHER NONCONTAGIOUS RISK FACTORS PETER H. DUESBERG Department of Molecular and Cell Biology, 229 Stanley Hall, University of California at Berkeley, Berkeley, CA 94720, U.S.A.
4.2. Overlap Between Drug-Use and AIDS Statistics Drugs and AIDS appear to claim their victims from the same risk groups. For instance, the CDC reports that the annual mortality of 25- to 44-year- old American males increased from 0.21% in 1983 to 0.23% in 1987, corresponding to about 10,000 deaths among about 50 million in this group (Buehler et al., 1990). Since the annual AIDS deaths had also reached 10,000 by 1987, HIV was assumed to be the cause (Institute of Medicine, 1986; Centers for Disease Control, 1987, 1992b). Further, HIV infection was blamed for a new epidemic of immunological and neurological deficiencies, including mental retardation, in American children (Blattner et al., 1988; Institute of Medicine, 1988; Centers for Disease Control, 1992b).
However, mortality in 25- to 44-year-old males from septicemia, considered an indicator of intravenous drug use, rose almost 4-fold from 0.46 per 100,000 in 1980 to 1.65 in 1987, and direct mortality from drug use doubled (National Center for Health Statistics, 1989; Buehler et al., 1990), indicating that drugs played a significant role in the increased mortality of this group (Buehler et al., 1990). In addition, deaths from AIDS diseases and nonAIDS pneumonia and septicemia per 1000 intravenous drug users in New York increased at exactly the same rates, from 3.6 in 1984 to 14.7 and 13.6, respectively, in 1987 (Selwyn et al., 1989).
Indeed, the cocaine-related hospital emergencies alone could more than account for the 32% of American AIDS patients that are intravenous drug users (Section 2.1.3). The emergencies had increased from "a negligible number of people" in 1973 to 9946 non-fatal and 580 fatal cases in 1985 (Kozel and Adams, 1986), when a total of 10,489 AIDS cases were recorded and to 80,355 nonfatal and 2483 fatal cases in 1990 (National Institute on Drug Abuse, 1990a,b), when a total of 41,416 AIDS cases were recorded by the CDC (Centers for Disease Control, 1992a). Moreover 82% of the cocaine-related and 75% of the morphine-related hospital emergencies were 20-39 years old (National Institute on Drug Abuse, 1990a), the age distribution typical of AIDS patients (Section 2.1.1).
Another striking coincidence is that over 72% of all American AIDS patients (Centers for Disease Control, 1992b) and about 75% of all Americans who consume "hard" psychoactive drugs such as cocaine, amphetamines and inhalants (National Institute on Drug Abuse, 1987, 1990a,b; Ginzburg, 1988) or get arrested for possession of such drugs (Bureau of Justice Statistics, 1988) or are treated for such drugs (National Institute on Drug Abuse, 1990a) are 20- to 44-year-old males. Thus there is substantial epidemiological overlap between the two epidemics (Lerner, 1989), reported as "The twin epidemics of substance use and HIV" by the National AIDS Commission (National Commission on AIDS, 1991).
Moreover, maternal drug consumption was blamed by some for the new epidemic of immunological and neurological deficiencies, including dementias, of American children (Toufexis, 1991). In view of this, the CDC acknowledges, "We cannot discern, however, to what extent the upward trend in death rates from drug abuse reflects trends in illicit drug use independent of the HIV epidemic" (Buehler et al., 1990). 4.3. Drug Use in AIDS Risk Groups 4.3.1. Intravenous Drug Users Generate a Third of All AIDS Patients Currently 32% of the American (National Commission on AIDS, 1991; Centers for Disease Control, 1992b) and 33% of the European (Brenner et al., 1990; World Health Organization, 1992a) AIDS patients are intravenous or intrauterine users of heroin, cocaine, and other drugs (Section 2.1.3). These include: (1) 75% of all heterosexual AIDS cases in America and about 70% of those in Europe, (2) 71% of the American and 57% of the European females with AIDS, (3) over 10% of the American and 5% of the European male homosexuals, (4) 10% of the American hemophiliacs with AIDS, (5) 70% of American children with AIDS including 50% born to mothers who are confirmed intravenous drug users and another 20% to mothers who had "sex with intravenous drug users" and are thus likely users themselves (Amaro et al., 1989), (6) 80-85% of the European children with AIDS who were born to drug- addicted mothers (Mok et al., 1987; European Collaborative Study, 1991).
In an article entitled "AIDS and intravenous drug use: the real heterosexual epidemic" the AIDS researcher Moss points out that "90% of infected prostitutes reported in Florida, Seattle, New York and San Francisco have been intravenous drug users ... Drug use is also the source of most neonatal AIDS, with 70% of cases occurring in children of intravenous drug users ..." (Moss, 1987).
Indeed, all studies of American and European prostitutes indicate that HIV infection is almost exclusively restricted to drug users (Rosenberg and Weiner, 1988), although all prostitutes should have the same risks of HIV infection, if HIV were sexually transmitted. Surprisingly, all of these studies only mention the incidence of HIV, rather than of AIDS, in prostitutes.
The Drug-AIDS Hypothesis, Peter Duesberg and David Rasnick.
The chronology and epidemiology of the American and European drug epidemics, which affects primarily 25-54 year old males, coincide exactly with the AIDS epidemic. Moreover, a comparison of the long-established list of drug diseases with the CDCs long catalogue of AIDS-defining diseases proves that drugs alone could be responsible for the AIDS epidemic. It is for this reason that throughout the epidemic drug-aware AIDS researchers found it difficult to distinguish between the drug and AIDS epidemics as the following titles of their articles indicate:
1) 1987: AIDS and intravenous drug use: the real heterosexual epidemic (145). 2) 1989: Cocaine abuse and acquired immunodeficiency syndrome: tale of two epidemics (121). 3) 1991: The Twin Epidemics of Substance Use and HIV (21). 4) 1991: AIDS, drugs of abuse and the immune system: a complex immunotoxicological network (124). 5) 1993: Entangled epidemics: cocaine use and HIV disease (123). 6) 1995: New picture of who will get AIDS is dominated by addicts (146). 7) 1996: Clinical features of drug use and drug use related to HIV (40).
Competing interests: None declared